FOXO

Foxo Technologies Inc. (FOXO) | Rumor.io

Foxo Technologies

FOXO

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)67%

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)16.4M

Net income (annual)-12.4M

Social

What share of all stock conversation is about FOXO?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% +0	0% -0.01

Nov 6

$FOXO is expected to explode and reach over 50 soon, with a rising BID and higher base formation.
The company's float is locked after yesterday's trading, and it's already gaping up this morning, with double-digit gains expected.
$FOXO has a decent share structure and is undervalued, with a planned reverse split not mentioned in the company's filings, and is expected to reach pennies in the near future.

Generated by AI

Sentiment

Of the messages about FOXO that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	100% new	66.67%	73.02% -11.29
Bearish	—	0% -100	33.33%	26.98% +11.29

Bullish· Nov 5

$FOXO has a strong share structure that can support a significant price increase.
The stock has seen a significant gap up in price, from $0.25 to $0.08, and is expected to continue running.
$FOXO has a thin level 2 market, making it vulnerable to a large price increase, and is expected to reach prices above $0.0060.

Bearish· Aug 12

$FOXO is at risk of delisting due to its low market capitalization, currently below $0.1.
The company's financials are a concern, with expenses exceeding revenues and a capital structure that includes convertible preferred shares, similar to those used by its CEO in a previous company that was delisted.
$FOXO has failed to commercialize its products, including insurance policies, a bio-lab service, and a Vithar app, and has struggled to attract top talent and investors, with a small team and declining revenue.

Generated by AI

Topics

Of the messages about FOXO that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	0%	5.78%
Announcements	—	—	100%	66.97%
Controversies	—	—	0%	0.15%
Earnings	—	—	0%	0%
Macro	—	—	0%	8.07%
Technical Analysis	—	—	0%	19.03%

Announcements· May 6

FOXO Technologies Inc.'s behavioral health subsidiary, Myrtle Recovery Centers, Inc., has achieved key patient care milestones, according to a Form 8-K filing.
The subsidiary has reached operational milestones, as announced by FOXO Technologies Inc. in a press release.
FOXO Technologies Inc. filed a Form 8-K on May 6, 2025, disclosing that its behavioral health subsidiary has achieved key patient care milestones.

Technical Analysis· May 6

The ascending triangle pattern on $FOXO's chart suggests a potential breakout above $2.20, with a target price of $2.50.
A bullish pennant formation is identified on the chart, indicating a possible continuation of the upward trend, with a buy entry at $2.50 on a breakout.
The stock is holding support nicely, with the next leg of the upward trend imminent, and a potential target price of $5 if it breaks and holds above $2.50.

Generated by AI

Community

Of the messages about FOXO, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	66.67%	5.61%	46.56%
Newcomers	—	33.33%	94.39%	53.44%

Regulars· May 6

The behavioral health subsidiary of FOXO Technologies Inc. has reached key operational milestones, with the company announcing this on May 6, 2025.
The stock has shown a pattern of squeezing shorts, with four instances in November 2024, and the current price action is being closely watched for potential entry points.
The stock's price action is being closely monitored, with the current price stuck at around $2.20, and traders are looking for a potential fade and support to form later in the day for another entry long.

Newcomers· May 6

New investors are expressing frustration with short-selling strategies, acknowledging their lack of understanding but aiming to learn and become profitable.
Some newcomers are discouraged by losses in $FOXO, citing difficulties in finding a trading strategy and struggling with the asset's volatility.
Others are setting price targets and suggesting buy and sell entry points, including a potential breakout at $2.50 or a dip at $1.00-$1.50, with a profit target of $4.00-$6.00.

Generated by AI

WEST PALM BEACH, FL, July 29, 2026 (GLOBE NEWSWIRE) -- FOXO Technologies Inc.’s (OTC: FOXOD/FOXO) ( “FOXO”) subsidiary, Vector BioSource, Inc. (“Vector”) today announced that it has entered into a definitive agreement to acquire four U.S.-based blood collection centers (the “Agreement”) from Grifols Bio Supplies, Inc., a U.S.-based subsidiary of Grifols S.A. The acquisition is intended to provide a proprietary source of bio-products to sell to Vector’s customers to augment its existing sourcing

2mo agoYahoo Finance

Also Discussed

Investors talking about FOXO also mention

#	Name	Attention
1	Freight Technologies, Inc.FRGT	0%-0.01
2	ZVSA - ZyVersa Therapeutics, Inc.	——
3	BSFC - Blue Star Foods Corp.	——
4	NMHI - Nature's Miracle Holding Inc.	——
5	Crown Electrokinetics Corp.CRKN	0%0
6	AREB - American Rebel Holdings, Inc.	——
7	NVOS - Novo Integrated Sciences, Inc.	——
8	BTC Digital Ltd.BTCT	0%0
9	Femto Technologies Inc.BCAN	0%0
10	Lucyd, Inc.LUCY	0%0

Foxo Technologies Inc.

Healthcare
Medical Care Facilities

Foxo Technologies Inc. is a pioneering biotechnology company that focuses on integrating epigenetic science with longevity science to revolutionize the life insurance industry. The firm’s primary aim is to develop and market an advanced suite of epigenetic biomarkers that can be utilized to assess the biological age and health of individuals more accurately and comprehensively. These biomarkers hold significant potential for transforming underwriting standards within life insurance, offering a more personalized and scientifically robust approach to risk assessment. Foxo Technologies operates at the intersection of technology, insurance, and health sciences, impacting these sectors by enabling more precise health evaluations and promoting preventative health strategies. With its innovative approach, the company plays a critical role in advancing personalized healthcare management and insurance, positioning itself as a leader in the integration of deep-seated scientific knowledge with the procedural rigors of risk and longevity analysis, thus marking its significance in the evolving landscape of health-tech and insurtech industries.

Website

Location

477 South Rosemary Ave.

West Palm Beach, FL, 33401

United States

Social

What share of all stock conversation is about FOXO?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% +0	0% -0.01

Nov 6

$FOXO is expected to explode and reach over 50 soon, with a rising BID and higher base formation.
The company's float is locked after yesterday's trading, and it's already gaping up this morning, with double-digit gains expected.
$FOXO has a decent share structure and is undervalued, with a planned reverse split not mentioned in the company's filings, and is expected to reach pennies in the near future.

Generated by AI

Sentiment

Of the messages about FOXO that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	100% new	66.67%	73.02% -11.29
Bearish	—	0% -100	33.33%	26.98% +11.29

Bullish· Nov 5

$FOXO has a strong share structure that can support a significant price increase.
The stock has seen a significant gap up in price, from $0.25 to $0.08, and is expected to continue running.
$FOXO has a thin level 2 market, making it vulnerable to a large price increase, and is expected to reach prices above $0.0060.

Bearish· Aug 12

$FOXO is at risk of delisting due to its low market capitalization, currently below $0.1.
The company's financials are a concern, with expenses exceeding revenues and a capital structure that includes convertible preferred shares, similar to those used by its CEO in a previous company that was delisted.
$FOXO has failed to commercialize its products, including insurance policies, a bio-lab service, and a Vithar app, and has struggled to attract top talent and investors, with a small team and declining revenue.

Generated by AI

Topics

Of the messages about FOXO that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	0%	5.78%
Announcements	—	—	100%	66.97%
Controversies	—	—	0%	0.15%
Earnings	—	—	0%	0%
Macro	—	—	0%	8.07%
Technical Analysis	—	—	0%	19.03%

Announcements· May 6

FOXO Technologies Inc.'s behavioral health subsidiary, Myrtle Recovery Centers, Inc., has achieved key patient care milestones, according to a Form 8-K filing.
The subsidiary has reached operational milestones, as announced by FOXO Technologies Inc. in a press release.
FOXO Technologies Inc. filed a Form 8-K on May 6, 2025, disclosing that its behavioral health subsidiary has achieved key patient care milestones.

Technical Analysis· May 6

The ascending triangle pattern on $FOXO's chart suggests a potential breakout above $2.20, with a target price of $2.50.
A bullish pennant formation is identified on the chart, indicating a possible continuation of the upward trend, with a buy entry at $2.50 on a breakout.
The stock is holding support nicely, with the next leg of the upward trend imminent, and a potential target price of $5 if it breaks and holds above $2.50.

Generated by AI

Community

Of the messages about FOXO, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	66.67%	5.61%	46.56%
Newcomers	—	33.33%	94.39%	53.44%

Regulars· May 6

The behavioral health subsidiary of FOXO Technologies Inc. has reached key operational milestones, with the company announcing this on May 6, 2025.
The stock has shown a pattern of squeezing shorts, with four instances in November 2024, and the current price action is being closely watched for potential entry points.
The stock's price action is being closely monitored, with the current price stuck at around $2.20, and traders are looking for a potential fade and support to form later in the day for another entry long.

Newcomers· May 6

New investors are expressing frustration with short-selling strategies, acknowledging their lack of understanding but aiming to learn and become profitable.
Some newcomers are discouraged by losses in $FOXO, citing difficulties in finding a trading strategy and struggling with the asset's volatility.
Others are setting price targets and suggesting buy and sell entry points, including a potential breakout at $2.50 or a dip at $1.00-$1.50, with a profit target of $4.00-$6.00.

Generated by AI

Foxo Technologies

Social

Nov 6

Sentiment

Bullish· Nov 5

Bearish· Aug 12

Topics

Announcements· May 6

Technical Analysis· May 6

Community

Regulars· May 6

Newcomers· May 6

News

FOXO TECHNOLOGIES INC.’S SUBSIDIARY VECTOR BIOSOURCE, INC. ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE FOUR BLOOD COLLECTION CENTERS FROM GRIFOLS BIO SUPPLIES, INC.

Also Discussed

Foxo Technologies Inc.

Company Information

Location

News

FOXO TECHNOLOGIES INC.’S SUBSIDIARY VECTOR BIOSOURCE, INC. ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE FOUR BLOOD COLLECTION CENTERS FROM GRIFOLS BIO SUPPLIES, INC.

Also Discussed

Social

Nov 6

Sentiment

Bullish· Nov 5

Bearish· Aug 12

Topics

Announcements· May 6

Technical Analysis· May 6

Community

Regulars· May 6

Newcomers· May 6